For this patient, two putative metastatic driver mutations were detected within rare populations of cells within the primary tumor: a mutation in PEAK1 (K140Q), which is a focal adhesion kinase involved in cell migration that is significantly and preferentially mutated in metastases [7], and a mutation in the WNT co-receptor, LRP5 A65V. This evidence concerns the gene PEAK1 and neoplasm.